Results 141 to 150 of about 44,256 (203)

Innate immunity in tumors: roles and therapeutic targets. [PDF]

Front Immunol
Leng S, Ren Y, Tian Y, Zhao W, Mou Y, Chen X, Zhou H, Wang W.   +7 more
europepmc   +1 more source

Phage Display Reveals VLRB-Mediated Recognition of Minimal Tumor Glycan Antigen Sialyl-Tn. [PDF]

Curr Issues Mol Biol
Angelia MRN, Rodelas-Angelia AJD, Kim Y, Yang C, Jang H, Jeong S, Mun J, Thompson KD, Jung T.   +8 more
europepmc   +1 more source

Metformin combined with progesterone improves efficacy and reduces adverse reactions in early endometrial cancer. [PDF]

Am J Transl Res
Li J, Hou Y, Liao D.
europepmc   +1 more source

Hemocyanins: Microscopic Giants with Unique Structural Features for Applications in Biomedicine. [PDF]

Vaccines (Basel)
Salazar ML, Díaz-Dinamarca DA, Bustamante J, Vergara F, Manubens A, Salazar F, Becker MI.   +6 more
europepmc   +1 more source

Targeting high endothelial venules: potential strategies for cancer treatment. [PDF]

Ann Med
Yang W, Zhu G, Cai S, Xing H, Yang A, Ye X.   +5 more
europepmc   +1 more source

Editor's Choice Protein engineering strategies to develop lectins by design. [PDF]

Glycobiology
Hombu R, Beatty LE, Neelamegham S.
europepmc   +1 more source

Prolonged Diagnostic Latency and Long-term Surveillance in Anti-Ri Antibody-positive Opsoclonus-myoclonus Syndrome with Carcinoma of Unknown Primary. [PDF]

Intern Med
Ibukuro M, Kida H, Sarukawa H, Komatsu T, Sakai K, Iguchi Y.   +5 more
europepmc   +1 more source

Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. [PDF]

Cell
Zhou RW, Purohit PK, Kim JH, Lee SU, Burshteyn N, Tifrea D, Cordon A, Grigorian A, Newton BL, Edwards RA, Demetriou M.   +10 more
europepmc   +1 more source

The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy. [PDF]

Cell Death Dis
Xie Z, Fang Y, Zhang X, Fang Y, Li R, Guo Y, Yang Y, Yang S, Song L.   +8 more
europepmc   +1 more source

A ribonucleotide carbohydrate system (iRNC) enhances antigen presentation and controls glioblastoma. [PDF]

Theranostics
Kim HS, Oh J, Jeon J, Fei F, Parvanian S, Kohler R, Garris C, Weissleder R.   +7 more
europepmc   +1 more source